Exact Sciences Corp. Files Q1 2025 10-Q
Ticker: EXAS · Form: 10-Q · Filed: 2025-05-01T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, quarterly-report, healthcare
Related Tickers: EXAS
TL;DR
EXAS Q1 2025 10-Q filed. Financials updated.
AI Summary
Exact Sciences Corp. reported its first quarter 2025 results, ending March 31, 2025. The company's filing details its financial position and operational performance for the period. Specific financial figures and operational metrics are provided within the report.
Why It Matters
This filing provides investors and analysts with the latest financial performance data for Exact Sciences Corp., crucial for understanding the company's current health and future prospects.
Risk Assessment
Risk Level: medium — The company operates in the highly competitive and regulated healthcare sector, facing risks related to product development, market adoption, and reimbursement.
Key Numbers
- 2025-03-31 — Period End Date (Quarterly reporting period)
- 2025-01-01 — Period Start Date (Quarterly reporting period)
- 2024-12-31 — Previous Year End Date (Comparison point for financial data)
Key Players & Entities
- EXACT SCIENCES CORP (company) — Filer
- 20250331 (date) — Period of Report
- 20250501 (date) — Filing Date
- MADISON (location) — Business Address City
- WI (location) — Business Address State
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the first quarter of 2025, ending on March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed with the SEC on May 1, 2025.
What is the company's principal executive office location?
The company's principal executive office is located at 5505 Endeavor Lane, Madison, WI.
What is the Standard Industrial Classification (SIC) code for Exact Sciences Corp.?
The SIC code for Exact Sciences Corp. is 8071, which falls under SERVICES-MEDICAL LABORATORIES.
What fiscal year end does Exact Sciences Corp. observe?
Exact Sciences Corp. observes a fiscal year end on December 31.
From the Filing
0001124140-25-000043.txt : 20250501 0001124140-25-000043.hdr.sgml : 20250501 20250501170820 ACCESSION NUMBER: 0001124140-25-000043 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 97 CONFORMED PERIOD OF REPORT: 20250331 FILED AS OF DATE: 20250501 DATE AS OF CHANGE: 20250501 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EXACT SCIENCES CORP CENTRAL INDEX KEY: 0001124140 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 204782291 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-35092 FILM NUMBER: 25904284 BUSINESS ADDRESS: STREET 1: 5505 ENDEAVOR LANE CITY: MADISON STATE: WI ZIP: 53719 BUSINESS PHONE: 608-284-5700 MAIL ADDRESS: STREET 1: 5505 ENDEAVOR LANE CITY: MADISON STATE: WI ZIP: 53719 FORMER COMPANY: FORMER CONFORMED NAME: EXACT CORP DATE OF NAME CHANGE: 20000919 10-Q 1 exas-20250331.htm 10-Q exas-20250331 2025 Q1 0001124140 false --12-31 http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/srt/2024#ChiefExecutiveOfficerMember 1 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure exas:reportable_segment exas:segment 0001124140 2025-01-01 2025-03-31 0001124140 2025-04-30 0001124140 2025-03-31 0001124140 2024-12-31 0001124140 2024-01-01 2024-03-31 0001124140 us-gaap:CommonStockMember 2024-12-31 0001124140 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001124140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001124140 us-gaap:RetainedEarningsMember 2024-12-31 0001124140 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001124140 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001124140 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001124140 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001124140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0001124140 us-gaap:CommonStockMember 2025-03-31 0001124140 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001124140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001124140 us-gaap:RetainedEarningsMember 2025-03-31 0001124140 2024-03-31 0001124140 us-gaap:CommonStockMember 2023-12-31 0001124140 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001124140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001124140 us-gaap:RetainedEarningsMember 2023-12-31 0001124140 2023-12-31 0001124140 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001124140 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001124140 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001124140 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001124140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001124140 us-gaap:CommonStockMember 2024-03-31 0001124140 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001124140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001124140 us-gaap:RetainedEarningsMember 2024-03-31 0001124140 us-gaap:CostOfSalesMember 2024-01-01 2024-03-31 0001124140 us-gaap:ResearchAndDevelopmentExpenseMember 2024-01-01 2024-03-31 0001124140 us-gaap:SellingAndMarketingExpenseMember 2024-01-01 2024-03-31 0001124140 us-gaap:GeneralAndAdministrativeExpenseMember 2024-01-01 2024-03-31 0001124140 us-gaap:ConvertibleNotesPayableMember 2025-01-01 2025-03-31 0001124140 us-gaap:ConvertibleNotesPayableMember 2024-01-01 2024-03-31 0001124140 us-gaap:RestrictedStockMember 2025-01-01 2025-03-31 0001124140 us-gaap:RestrictedStockMember 2024-01-01 2024-03-31 0001124140 us-gaap:PerformanceSharesMember 2025-01-01 2025-03-31 0001124140 us-gaap:PerformanceSharesMember 2024-01-01 2024-03-31 0001124140 exas:EmployeeAndNonE